Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the details of the Analyst/ Investor Meetings to be attended by the Company are enclosed herewith.

pdf

Supriya Lifescience Ltd.

10 Mar 2025

668.05

-0.76%

Company Update

Supriya Lifescience Ltd - 543434 - Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI …

BSE India

Please find attached the details of KMP

pdf

Supriya Lifescience Ltd.

10 Mar 2025

668.05

-0.76%

Company Update

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

The Board of Directors at their meeting held on March 10, 2025, inter alia have considered and approved the 1.appointment of Ms. Prachi Sathe bearing Membership No. A- 70252 as the Company Secretary and Compliance Officer of the Company with effect from March 10, 2025 2. Any other matter incidental to the appointment of Company Secretary and Compliance Officer. Kindly take the same on record.

pdf

Supriya Lifescience Ltd.

10 Mar 2025

668.05

-0.76%

Company Update

Supriya Lifescience Ltd - 543434 - Appointment of Company Secretary and Compliance Officer

BSE India

The Board of Directors at their meeting held on March 10, 2025, inter alia considered and approved: 1. Appointment of Ms. Prachi Sathe bearing Membership No. A-70252 as Company Secretary & Compliance Officer of the Company with effect from March 10, 2025, on the basis of recommendations received from the Nomination and Remuneration Committee of the Company; 2. Any other matters incidental with the appointment of Company Secretary and Compliance Officer. The details required as per SEBI Circular dated 09.09.2025 and Brief profile is attached herewith. Kindly take the same on record.

pdf

Supriya Lifescience Ltd.

10 Mar 2025

668.05

-0.76%

Board Meeting

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting Held To …

BSE India

With reference to above subject matter and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at their meeting held on Monday, March 10, inter alia considered and approved the following businesses: 1. Appointment of Ms. Prachi Sathe bearing Membership No. A-70252 as Company Secretary and Compliance Officer of the Company with effect from March 10, 2025, on the basis of recommendations received from the Nomination and Remuneration Committee of the Company; 2. Any other matters incidental with the appointment of Company Secretary and Compliance Officer of the Company; Brief profile as per SEBI circular is attached. The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.00 noon. Kindly take the same on record.

pdf

Supriya Lifescience Ltd.

05 Mar 2025

668.05

-0.76%

Board Meeting

Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Appointment Of Company Secretary And Compliance …

BSE India

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2025 ,inter alia, to consider and approve With reference to above subject matter and pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday, March 10, 2025 at 11.30 a.m at the registered office of the Company to consider and transact the following businesses: 1. Appointment of Company Secretary and Compliance Officer of the Company; 2. Any other matter with the permission of the chair. Kindly take the above information on your records.

pdf

VOTE: Is Supriya Lifescience Ltd. worth buying?

109 Votes:

Buy 86.24%

Sell 6.42%

Hold 7.34%